How Can I Check My Melatonin Levels?
How Can I Check My Melatonin Levels?
Your body produces melatonin — a hormone that regulates sleep and circadian timing — in a highly predictable pattern: near zero during the day, peaking at 80–120 pg/mL around the middle of the night. When something disrupts that rhythm — poor sleep, jet lag, shift work, or unexplained fatigue — it's natural to wonder whether a melatonin test can explain what's going wrong. The honest answer: yes, testing is possible, but understanding what it can and can't tell you will save you time, money, and confusion.
Key Takeaways
- Three testing methods exist — blood, saliva, and urine — and each measures a different thing; results from one method cannot be directly compared to another.
- Saliva is the most practical option for most people: salivary melatonin levels run about 3x lower than plasma, with a standard DLMO threshold of 3–4 pg/mL.
- "Normal" varies enormously — in healthy adults, peak nighttime melatonin ranges from 18 to 197 pg/mL depending on the individual and sex, making a single snapshot hard to interpret.
- The most clinically useful test is DLMO (Dim Light Melatonin Onset), which measures when melatonin starts to rise — not just how much — and improves treatment outcomes for circadian rhythm disorders.
- For most adults with garden-variety sleep difficulties, formal melatonin testing is rarely necessary; NIH guidance does not recommend routine testing before trying evidence-based supplementation strategies.
Table of Contents
- How Your Body Makes and Uses Melatonin
- The 3 Ways to Test Melatonin Levels: Blood, Saliva, and Urine
- DLMO: The Most Clinically Useful Melatonin Test
- What Your Results Mean — and Why Normal Varies So Much
- Who Actually Benefits from Melatonin Testing?
- What Affects Your Melatonin Levels Before and During Testing
- When Supplementation Makes More Sense Than Testing
- Frequently Asked Questions
- Conclusion
- Research References
1. How Your Body Makes and Uses Melatonin
Melatonin is synthesized in the pineal gland — a pea-sized structure in the center of the brain — through a 4-step process that begins with the amino acid tryptophan. Tryptophan is first converted to serotonin, which is then acetylated and methylated into melatonin under the regulation of the suprachiasmatic nucleus (SCN), your body's master clock. The entire process is tightly controlled by light: darkness triggers production, while even brief light exposure — including a 30-lux phone screen — can suppress it rapidly.
During the day, plasma melatonin sits at just 10–20 pg/mL. After dusk, levels rise sharply, reaching their nightly peak of 80–120 pg/mL in healthy adults, typically around 2–3 AM. By early morning, the pineal gland shuts down production and levels drop back to daytime baseline within minutes of sunrise. This nightly rhythm isn't just about feeling sleepy — melatonin coordinates immune function, body temperature regulation, and antioxidant defense across every cell in the body.
Critically, melatonin levels decline with age. A systematic review of healthy older adults found that while total 24-hour melatonin production may remain roughly stable, peak nocturnal concentrations can decline significantly — which helps explain why sleep architecture changes in middle age and beyond. Understanding this baseline biology is essential context for interpreting any test result you receive.
2. The 3 Ways to Test Melatonin Levels: Blood, Saliva, and Urine
There is no single universal melatonin test. The 3 available methods each measure a different form of melatonin or its metabolites, have different practical requirements, and are suited to different situations. A systematic review of melatonin measurement methods confirms that one test result should never be compared directly to another — the numbers are simply not interchangeable.
- Blood (plasma/serum): The most accurate method, measuring free melatonin in plasma at concentrations up to 80–120 pg/mL at peak. Requires repeated blood draws in a clinical setting over several hours, which is impractical for most patients and rarely done outside research settings.
- Saliva: The most practical option for both clinical and at-home use. Salivary melatonin runs approximately 30–40% of plasma levels, with a standard DLMO threshold of 3–4 pg/mL. Requires dim-light conditions (<30 lux) during collection. Multiple timed samples collected over 4–7 hours produce reliable results.
- Urine: Measures 6-sulphatoxymelatonin (aMT6s), the primary metabolite of melatonin excreted by the kidneys. Collecting aMT6s every 2–8 hours over 24–48 hours is an established method for estimating total melatonin production, but a single morning void gives only a rough overnight average and can be distorted by kidney function and hydration levels.
At-home consumer testing is available via CLIA-certified laboratories such as ZRT Laboratory, which offers at-home saliva-based melatonin panels collected via timed samples sent back for lab analysis. Results typically arrive within 5–7 business days. These tests are a legitimate option but require strict adherence to collection protocols — particularly around light exposure — to produce meaningful data.
3. DLMO: The Most Clinically Useful Melatonin Test
DLMO stands for Dim Light Melatonin Onset — the precise time at which your melatonin levels begin to rise under dim light conditions. Research consistently identifies DLMO as the single most accurate marker for assessing the circadian pacemaker, more reliable than sleep diaries, actigraphy watches, or subjective chronotype questionnaires. In people with normally entrained rhythms, DLMO occurs roughly 2–3 hours before habitual bedtime. When it's shifted — earlier or later than expected — it reveals actual circadian misalignment, not just a sleep perception problem.
DLMO testing requires saliva or plasma samples collected every 30–60 minutes over a 4–7 hour evening window, under strict dim light conditions (<30 lux throughout). A landmark review found that collecting samples every 60 minutes for 6 hours is as accurate as every 30 minutes, making home-based DLMO testing feasible when protocols are followed carefully. The DLMO threshold for saliva is typically set at a fixed 3 pg/mL or 4 pg/mL — the time when your rising melatonin crosses that line is your result.
Why does DLMO matter clinically? Because knowing when your clock is set allows clinicians to time any intervention — light therapy, melatonin supplementation, or behavioral chronotherapy — to your actual biology rather than a generic schedule. Studies show that knowing a patient's DLMO before prescribing melatonin shortens the time to achieve results and improves treatment accuracy for conditions like Delayed Sleep Phase Syndrome (DSPS) and Non-24-Hour Sleep-Wake Disorder. For conditions like these, DLMO is a meaningful diagnostic tool — not a wellness curiosity.
4. What Your Results Mean — and Why Normal Varies So Much
Here is the honest challenge with melatonin testing: the reference range for healthy adults is extraordinarily wide. A study of 129 healthy volunteers found that at 3:00 AM, normal melatonin levels ranged from 18.3 to 134 pg/mL in males and 19.0 to 197 pg/mL in females — a nearly 10-fold spread within a completely healthy population. A result that looks "low" compared to average may still be normal for you. A result that looks "normal" compared to a reference table may represent a significant personal decline if you had higher levels in your 30s.
Timing adds another layer of complexity. In 170 healthy adults, the onset of melatonin secretion varied from 6:13 PM to 12:26 AM — a spread of over 6 hours between individuals, all of whom were healthy. This means a single snapshot blood draw at 10 PM might catch one person at their nightly peak and another before their melatonin has even started rising. Without knowing your personal baseline and timing, a single-point result is nearly impossible to interpret meaningfully.
What results can tell you reliably: DLMO timing (whether your clock is phase-delayed or advanced), gross absence of nocturnal production (which points to pineal dysfunction or a major suppressive factor like beta-blockers), and trends over time when tested under identical conditions. What they cannot tell you: whether you are "melatonin deficient" in a clinically defined sense, or whether supplementation would help your sleep, without additional clinical context.
5. Who Actually Benefits from Melatonin Testing?
Formal melatonin testing is genuinely valuable for a specific subset of people — those with suspected circadian rhythm disorders where the timing of intervention matters. The conditions where DLMO testing has the strongest evidence base include Delayed Sleep Phase Syndrome (DSPS), Non-24-Hour Sleep-Wake Disorder (common in blind individuals), Advanced Sleep Phase Syndrome, and Shift Work Sleep Disorder. For these conditions, knowing your circadian phase — not just your sleep complaints — allows targeted treatment. DLMO is also used clinically to evaluate seasonal affective disorder (SAD) and mood disorders with a circadian component.
Testing is also appropriate when a physician suspects that medication is suppressing melatonin. Beta-blockers — prescribed to millions of adults for hypertension and heart disease — are documented to significantly reduce natural melatonin production. In people over 55 with sleep difficulties, melatonin production is measurably lower than in age-matched healthy controls, and a test can help a clinician decide whether supplementation is appropriate and at what dose.
For everyone else — adults who simply have trouble falling asleep, wake at night, or feel unrested — formal testing is rarely the right first step. The NIH does not recommend routine melatonin level testing before trialing supplementation. Sleep problems in this group are more commonly related to sleep hygiene, circadian misalignment from light exposure habits, stress, or suboptimal supplementation timing — all of which can be addressed without laboratory data. If sleep issues persist after 4–6 weeks of evidence-based strategies, a conversation with a sleep specialist (who can order DLMO if warranted) is more productive than a consumer test kit.
6. What Affects Your Melatonin Levels Before and During Testing
If you do decide to test, the validity of your results depends heavily on what you do in the hours before and during sample collection. Light is the most powerful suppressor: exposure to >30 lux — roughly the brightness of a dimly lit room — during the evening collection window will blunt your DLMO and produce falsely low results. Samples collected under standard indoor lighting rather than dim light conditions systematically underestimate true DLMO levels, which is the single most common source of error in at-home tests.
Several other factors can significantly alter your melatonin levels independent of your underlying biology:
- Beta-blockers: Can suppress nighttime melatonin production substantially, potentially distorting any test result.
- NSAIDs (aspirin, ibuprofen): Documented to suppress nighttime melatonin secretion at standard doses.
- Caffeine: 200 mg of caffeine (roughly 2 cups of coffee) consumed in the evening suppresses nighttime melatonin levels and shifts circadian temperature rhythms.
- SSRIs and some antidepressants: Can increase melatonin levels by elevating serotonin availability (melatonin's direct precursor).
Age is also a key variable. Healthy older adults may show lower peak nocturnal melatonin concentrations than younger adults, which is biologically normal rather than a sign of pathology. If you are testing without disclosing your age, medications, or light environment to whoever interprets your results, those results are likely to be misread. Any reputable lab or clinician will ask for this context before interpreting your numbers.
7. When Supplementation Makes More Sense Than Testing
For most adults with sleep difficulties not caused by a diagnosed circadian disorder, the practical path forward isn't a lab test — it's optimising melatonin levels through behavior and, where appropriate, supplementation. If you suspect low melatonin based on your symptoms (difficulty falling asleep, poor sleep quality, fatigue), the evidence-based approach is to address the most common suppressors first: reduce evening light exposure, limit caffeine after noon, and consider a low-dose melatonin supplement timed to 30–60 minutes before your intended sleep window. If symptoms improve consistently, that response is itself informative. If they don't, that's when a clinician and potentially a DLMO test become relevant.
When supplementation is the right choice, delivery method matters significantly. BioAbsorb Liposomal Liquid Melatonin achieves 80–95% bioavailability through liposomal encapsulation — compared to just 15–20% for standard tablets, which are largely broken down before reaching the bloodstream. Each 1 ml dropper delivers 5 mg, with a graduated dropper allowing increments as small as ~0.5 mg, so you can start at the lowest effective dose (often 0.5–1 mg for most adults) and adjust precisely. Onset is 15–30 minutes — roughly 3x faster than standard oral tablets at 60–90 minutes — which is clinically relevant for circadian timing protocols.
BioAbsorb Nutraceuticals manufactures in a GMP-certified, Health Canada-approved Canadian facility. Every batch is third-party tested with a Certificate of Analysis available on request. The formula is non-GMO, vegan, and gluten-free — at $29.99 for 100 ml (100 servings), it works out to under $0.30 per dose. For adults who want to support their melatonin system without first running lab work, this is a practical, evidence-aligned starting point.
Frequently Asked Questions
Can I test my melatonin levels at home?
Yes — at-home saliva testing is available through CLIA-certified laboratories such as ZRT Laboratory, which offer melatonin panels collected via timed saliva samples mailed to the lab. Results typically arrive within 5–7 business days. The critical caveat is that protocol adherence matters enormously: all samples must be collected in dim light (<30 lux), and multiple timed collections over 4–7 hours are needed to produce a meaningful DLMO profile rather than a single unreliable snapshot.
What is a "normal" melatonin level?
There is no single normal number. In healthy adults tested at 3 AM, melatonin levels range from approximately 18 to 197 pg/mL — a nearly 10-fold range — depending on the individual, age, sex, and test conditions. This wide variation is why clinical interpretation focuses on DLMO timing (when melatonin rises relative to your sleep schedule) rather than absolute numbers. A "low" result may be normal for you; a result in the middle of the reference range may still represent a personal decline. Context from a clinician familiar with circadian medicine is needed to interpret results meaningfully.
Does a low melatonin level mean I should take a supplement?
Not automatically. A low absolute level on a single test can reflect normal individual variation, poor test conditions (too much light during collection), medication effects (particularly beta-blockers), or age-related changes rather than a true deficiency requiring treatment. The better question is whether your sleep timing and quality are impaired — and if so, whether a low-dose melatonin supplement, properly timed, improves them. NIH guidance recommends discussing supplementation with a healthcare provider rather than self-diagnosing from a single test value.
Does the type of melatonin supplement affect its effectiveness?
Yes, significantly. Standard oral melatonin tablets have a bioavailability of just 15–20% because most of the dose is broken down during first-pass metabolism in the liver before reaching circulation. Liposomal delivery — the format used by BioAbsorb — achieves 80–95% bioavailability by encapsulating melatonin in phospholipid vesicles that bypass hepatic breakdown. This means a 0.5 mg liposomal dose may deliver more active melatonin to target tissues than a 3 mg standard tablet — which is why starting low and adjusting is the right approach with high-bioavailability formats.
Can my doctor order a melatonin test?
Yes. A physician or sleep specialist can order a formal DLMO assessment through a clinical sleep laboratory or a specialized hormone testing lab. This is most appropriate if you have a suspected circadian rhythm disorder, have failed standard sleep interventions, or are taking medications known to suppress melatonin. Research shows that measuring DLMO before treating circadian rhythm sleep disorders improves outcomes by allowing precise timing of light therapy or melatonin supplementation to your actual circadian phase rather than a generic protocol.
Is melatonin testing covered by insurance?
Melatonin testing is rarely covered by standard health insurance in the US when ordered for general sleep complaints. It is more likely to be covered — or at minimum reimbursable via HSA/FSA — when ordered by a physician as part of a diagnostic workup for a named circadian rhythm disorder. At-home consumer tests from labs like ZRT typically cost $150–$450 depending on the panel and are paid out of pocket. If cost is a concern, discuss with your doctor whether a clinical referral to a sleep centre might provide more comprehensive testing at lower net cost.
Conclusion
Testing your melatonin levels is possible — through blood, saliva, or urine — but the results are only as useful as the clinical context around them. For most people with common sleep difficulties, the data you actually need is about timing rather than absolute levels: that's what DLMO captures, and it's the metric that sleep researchers consistently identify as the most clinically meaningful. If you're not ready for formal testing, starting with a precisely dosed, high-bioavailability supplement — and tracking your sleep response over 4 weeks — gives you useful real-world data at a fraction of the cost. Explore BioAbsorb Liposomal Melatonin if you want a clean, accurately dosed option to start with.
Research References
- Measuring Melatonin in Humans. Journal of Clinical Sleep Medicine, Vol. 4 (2008). Consensus-based workgroup recommendations for collection and analysis of urinary, salivary, and plasma melatonin; establishes urine aMT6s sampling every 2–8 hours over 24–48 hours as a practical field and clinical method.
- Dim Light Melatonin Onset (DLMO): A Tool for the Analysis of Circadian Phase in Human Sleep and Chronobiological Disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, Vol. 30 (2006). Identifies DLMO as the single most accurate marker for assessing the circadian pacemaker; supports its use in diagnosing phase delays, advances, and mood disorders with a circadian component.
- Why the Dim Light Melatonin Onset (DLMO) Should Be Measured Before Treatment of Patients with Circadian Rhythm Sleep Disorders. Sleep Medicine Reviews, Vol. 18 (2014). Demonstrates that sleep diaries and polysomnography do not reliably predict DLMO; shows that measuring DLMO before treatment improves diagnostic accuracy and shortens time to therapeutic results.
- Melatonin-Measurement Methods and the Factors Modifying the Results: A Systematic Review of the Literature. International Journal of Molecular Sciences, Vol. 21 (2020). Comprehensive comparison of blood, saliva, and urine melatonin measurement; establishes that salivary melatonin is ~3x lower than plasma and that results across methods cannot be directly compared.
- Melatonin Reference Limits at 3:00 AM and 8:00 AM in Healthy Adults. Journal of Pineal Research, Vol. 49 (2010). Documents the wide inter-individual range of normal melatonin levels (18.3–197 pg/mL at 3 AM across 129 healthy adults), establishing why single-point results are difficult to interpret without personal baseline data.
- Individual Differences in the Amount and Timing of Salivary Melatonin Secretion. PLOS ONE, Vol. 3 (2008). In 170 healthy adults, peak salivary melatonin ranged from 2–84 pg/mL and onset ranged from 18:13 to 00:26 hours — a 6-hour spread in healthy individuals — supporting DLMO timing over absolute level as the primary clinical metric.
- Physiology of the Pineal Gland and Melatonin. Endotext — NCBI Bookshelf (2022). Peer-reviewed overview of melatonin biosynthesis from tryptophan via serotonin, SCN regulation, and normal plasma reference values (10–20 pg/mL daytime; 80–120 pg/mL nocturnal peak).
- Melatonin. StatPearls — NCBI Bookshelf (2024). Clinical reference covering melatonin physiology, receptor pharmacology, and the AAFP's recognition of melatonin as first-line pharmacological therapy for insomnia.
- Physiological Melatonin Levels in Healthy Older People: A Systematic Review. Journal of Psychosomatic Research, Vol. 86 (2016). Finds that while total 24-hour melatonin production may not change with healthy aging, peak nocturnal concentrations can decline — an important consideration when interpreting test results in adults over 55.
- Benefits and Adverse Events of Melatonin Use in the Elderly (Review). Experimental and Therapeutic Medicine, Vol. 23 (2022). Identifies beta-blockers, NSAIDs, and other common medications as documented suppressors of melatonin production, and confirms the role of testing in guiding supplementation in older adults on polypharmacy regimens.
- Caffeine and Light Effects on Nighttime Melatonin and Temperature Levels in Sleep-Deprived Humans. Sleep, Vol. 20 (1997). Demonstrates that 200 mg of caffeine consumed at night suppresses nighttime melatonin levels and blunts normal circadian temperature drop, with additive effects when combined with bright light exposure.
- Melatonin: What You Need to Know. National Institutes of Health — National Center for Complementary and Integrative Health (2023). Authoritative NIH consumer overview of melatonin's safety profile, evidence base, and appropriate usage guidance.
About the Author
David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.
Important Disclaimers
Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.
FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.